- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05658718
Factors Influencing Nocturnal Symptoms After Refractive Surgery.
September 6, 2023 updated by: Yifeng Yu, Second Affiliated Hospital of Nanchang University
Effects of Different Pupil Size Under Light and Dark Conditions on Nighttime Symptoms After Refractive Surgery.
By comparing the parameters of the two groups of patients with glare at night after refractive surgery and those without glare at night, the influence of preoperative related parameters on postoperative glare was analyzed.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangxi
-
Nanchang, Jiangxi, China, 330000
- The Second Affiliated Hospital of Nanchang University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 41 years (Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
People undergoing refractive surgery.
Description
Inclusion criteria:
- Age ≥18 years old;
- Stable diopter (diopter change less than 0.5D in the past 2 years);
- Best corrected distance visual acuity (CDVA) of 1.0 or better;
- Anterior chamber depth (ACD) ≥2.8 mm;
- Corneal endothelial cell density (ECD) ≥ 2 000 cells/mm.
Exclusion criteria:
- History of ocular trauma or surgery;
- Suspected keratoconus;
- Previous history of other ocular diseases such as corneal inflammation or edema, glaucoma, uveitis, retinal detachment, macular degeneration, cataract, amblyopia, etc.;
- History of severe dry eye;
- Patients with systemic diseases, such as hyperthyroidism or autoimmune diseases; or severe mental disorders, such as anxiety and depression.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
glare group.
Patients subjectively complained about glare and Binoptometer examination showed poor visual quality in dark environments, and they were classified as the glare group.
|
refractive surgery
|
|
non-glare group
The patients did not complain of glare and the Binoptometer examination showed good visual quality in a dark environment, and they were classified as the non-glare group.
|
refractive surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes of diopter under bright and dark pupils.
Time Frame: Preoperative
|
Use OPDScan Ⅲ to measure the parameters of both eyes
|
Preoperative
|
|
Changes of diopter under bright and dark pupils.
Time Frame: Day 7
|
Use OPDScan Ⅲ to measure the parameters of both eyes.
|
Day 7
|
|
Changes of diopter under bright and dark pupils.
Time Frame: Month 1
|
Use OPDScan Ⅲ to measure the parameters of both eyes.
|
Month 1
|
|
Changes of diopter under bright and dark pupils.
Time Frame: Month 3
|
Use OPDScan Ⅲ to measure the parameters of both eyes.
|
Month 3
|
|
Changes of diopter under bright and dark pupils.
Time Frame: Month 6
|
Use OPDScan Ⅲ to measure the parameters of both eyes.
|
Month 6
|
|
objective visual quality.
Time Frame: Day 7
|
Measurement of objective visual quality using Binopotometer.
|
Day 7
|
|
objective visual quality.
Time Frame: Month 1
|
Measurement of objective visual quality using Binopotometer and NIDEK Automatic computerized optometry instrument(ARK-1s).
|
Month 1
|
|
objective visual quality.
Time Frame: Month 3
|
Measurement of objective visual quality using Binopotometer.
|
Month 3
|
|
objective visual quality.
Time Frame: Month 6
|
Measurement of objective visual quality using Binopotometer.
|
Month 6
|
|
subjective visual quality
Time Frame: Day 7
|
Using visual quality questionnaire to evaluate patients' subjective visual quality.
|
Day 7
|
|
subjective visual quality
Time Frame: Month 1
|
Using visual quality questionnaire to evaluate patients' subjective visual quality.
|
Month 1
|
|
subjective visual quality
Time Frame: Month 3
|
Using visual quality questionnaire to evaluate patients' subjective visual quality.
|
Month 3
|
|
subjective visual quality
Time Frame: Month 6
|
Using visual quality questionnaire to evaluate patients' subjective visual quality.
|
Month 6
|
|
ICL Vault
Time Frame: Day 7
|
Measuring ICL vault with Pentacam
|
Day 7
|
|
ICL Vault
Time Frame: Month 1
|
Measuring ICL vault with Pentacam
|
Month 1
|
|
ICL Vault
Time Frame: Month 3
|
Measuring ICL vault with Pentacam
|
Month 3
|
|
ICL Vault
Time Frame: Month 6
|
Measuring ICL vault with Pentacam
|
Month 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2021
Primary Completion (Estimated)
December 1, 2023
Study Completion (Estimated)
December 1, 2023
Study Registration Dates
First Submitted
November 20, 2022
First Submitted That Met QC Criteria
December 13, 2022
First Posted (Actual)
December 21, 2022
Study Record Updates
Last Update Posted (Actual)
September 7, 2023
Last Update Submitted That Met QC Criteria
September 6, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- [2021] No. (113).
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Surgery
-
Suzan A RattanCompletedRefractive Errors | Refractive SurgeryIraq
-
Wenzhou Medical UniversityCompletedRefractive Surgery
-
Affiliated Hospital of Nantong UniversityRecruitingClinical Application Research of 5-Degree (0.05 D) Precision Optometry in Corneal Refractive SurgeryRefractive SurgeryChina
-
Vance Thompson VisionUnknownRefractive SurgeryUnited States
-
Affiliated Hospital of Nantong UniversityRecruitingRefractive Surgery | Myopia; Refractive ErrorChina
-
Cairo UniversityCompletedRefractive SurgeryEgypt
-
Kasr El Aini HospitalEyecare CenterCompleted
-
Vissum, Instituto Oftalmológico de AlicanteAarhus University Hospital; Centro Hospitalar e Universitário de Coimbra, E... and other collaboratorsCompletedIndividualized Refractive SurgerySpain
-
Minia UniversityCompletedMyopia | Refractive SurgerySaudi Arabia, Egypt
Clinical Trials on refractive surgery
-
Deb GrzybowskiCompleted
-
Kasr El Aini HospitalEnrolling by invitationRefractive Errors | Myopia | Myopic AstigmatismEgypt
-
Tanta UniversityCompleted
-
Tanta UniversityUnknownMyopia | Perfusion; ComplicationsEgypt
-
Kasr El Aini HospitalNot yet recruitingFS-LASIK Surgery Effect on Higher Order AberrationsEgypt
-
Sohag UniversityNot yet recruitingConventional LASIK, Femto-LASIK and PRK in Low and Moderate Myopia
-
Shahid Beheshti University of Medical SciencesCompleted
-
Mayo ClinicNational Institutes of Health (NIH)Completed
-
Tianjin Eye HospitalNot yet recruitingRefractive Errors | Corneal Wavefront Aberration
-
Wenzhou Medical UniversityCompleted